Pro- and anti-fibrotic effects of TGF-β in scleroderma

Rheumatology

Volumn 47, Issue SUPPL. 5, 2009, Pages

  Sgonc, R ^a   Wick, Georg ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Fibrosis; Systemic sclerosis; The University of California at Davis 200 chicken; Transforming growth factor ; Transforming growth factor 2; Transforming growth factor 3

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 6; MESSENGER RNA; PLACEBO; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

CHICKEN; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DRUG EFFICACY; HUMAN; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCLERODERMA; SIGNAL TRANSDUCTION; SKIN FIBROSIS;

EID: 69949140810     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken275     Document Type: Conference Paper

References (10)

1. Sgonc R, Gruschwitz M, Dietrich H, Recheis H, Gershwin ME, Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J Clin Invest 1996;98:785-92.
2. Wick G, Andersson L, Hala K et al. Avian models with spontaneous autoimmune diseases. Adv Immunol 2006;92:71-117.
3. Denton CP, Black CM, Abraham DJ. Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2006;2:134-44.
4. Duncan MR, Wilson TJ, Van De Water J et al. Cultured fibroblasts in avian scleroderma, an autoimmune fibrotic disease, display an activated phenotype. J Autoimmunity 1992;5:603-15.
5. Sgonc R, Dietrich H, Gershwin ME, Colombatti A, Wick G. Genomic analysis of collagen and endogenous virus loci in the UCD-200 and 206 lines of chickens, animal models for scleroderma. J Autoimmunity 1995;8:763-70.
6. Ausserlechner MJ, Sgonc R, Dietrich H, Wick G. Altered procollagen mRNA expression during the progression of avian scleroderma. Mol Med 1997;3:654-62.
7. Leask A. Scar wars: Is TGFβ the phantom menace in scleroderma? Arthritis Res Ther 2006;8:213-19.
8. Prelog M, Scheidegger P, Peter S, Gershwin ME, Wick G, Sgonc R. Diminished TGF-β2 production leads to increased expression of a profibrotic procollagen alpha 2 type I mRNA variant in embryonic fibroblasts of UCD-200 chickens, a model for systemic sclerosis. Arthritis Rheum 2005;52:1804-11.
9. Blobe M, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000;342:1350-8.
10. Denton CP, Merkel PA, Furst DE et al. Cat-192 Study Group; Scleroderma Clinical Trials Consortium. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 2007;56:323-33.